Ranbaxy is a unique multinational pharmaceutical company that started in India in 1961 as a giant raw material company that manufacture and market high quality raw materials and export it to all big pharmaceutical companies worldwide

Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research.

The Company is selling its products in over 100 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries including USA and Europe.

Acquisitions by Ranbaxy:

	Ohm laboratories – USA.
	Rhone-Polenc-Rorer generic business - France.
	Basics Pharma (generic business of Bayer) – Germany.
	Rima pharma – Ireland.
	Terapia the largest generics pharmaceutical company in Romania.
	BeTabs – South Africa.

Ranbaxy manufacturing facilities is different from others as they are FDA approved (which means it has the right to manufacture and market its molecules in the USA) which assures quality raw materials that ensures first time clinical success and everlasting efficacy standards

Ranbaxy backward integration systems for its finished products illustrates our ability to offer high quality products at economic price

Ranbaxy ranks no 9th generic company worldwide, 2nd in generic business in USA and the 52nd in Egypt (of 600 companies working in the Egyptian Pharma Market).